Jpmorgan Chase & CO Enovis Corp Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Enovis Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 190,523 shares of ENOV stock, worth $8.62 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
190,523
Previous 300,190
36.53%
Holding current value
$8.62 Million
Previous $13.6 Million
39.55%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding ENOV
# of Institutions
310Shares Held
60.3MCall Options Held
1.68MPut Options Held
693K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.63MShares$300 Million0.17% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$245 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$245 Million0.0% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH3MShares$136 Million0.54% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.99MShares$135 Million0.03% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.45B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...